Effect of Kopalleum on skin scar

Evaluation of safety and efficacy of Kopalleum in management of dermal scar – A Non-invasive, prospective, Open Label, Single arm Clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044875

Enrollment

Registered

2022-08-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L905- Scar conditions and fibrosis of skin

Interventions

Intervention1: Kopalleum: Dermal Cream for skin application on scar. 1 gm of cream for 1 sq inch area of scar surface. Two times daily. After application do not wash. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Scar site completing more than 14 days of epithelialization 2. Immature and mature scar 3. Consent to take photograph of scar site

Exclusion criteria

Exclusion criteria: 1. Patients with critical illnesses such as those with systemic infection or hemodynamic instability. 2. Patients with a major acute or chronic medical illness that could have impact on the wound healing process. 3. Patients who were pregnant. 4. Patients who declined to participate

Design outcomes

Primary

Measure	Time frame
Difference in Manchester Scar Scale from baseline to final visitTimepoint: baseline, 3 months, 6 months	—

Secondary

Measure	Time frame
Difference in color, firmness and area based on equipment and photograph techniqueTimepoint: baseline, 3 months, 6 months	—

Countries

India

Contacts

Public ContactDr Nithin S U

SCORES research centre

nithinsu31@gmail.com8079624440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026